Skip to content

Welcome to Discover Pharma! Today is : November 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

fluoroquinolone resistance

  • Clinical & Regulatory

    Fonseca reports Phase 3 success for new swimmer’s ear treatment

    Fonseca Biosciences has reported positive pooled Phase 3 results for [...]

    November 18, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ViiV HIV medicines receive positive EU opinion for younger children
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ofichem agrees to acquire US CDMO Kinentia Biosciences
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
  • Thalia reports early clinical activity for AML RNA therapy miRisten
    Categories: Advanced Therapies, Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top